Artificial-Intelligence, Data-Driven, Comprehensive Classification of Myeloid Neoplasms Based on Genomic, Morphological and Histological Features
Luca Lanino(Humanitas University), David Quintela(Institut Català d'Oncologia), Hsin‐An Hou(National Taiwan University Hospital), Francesca Ficara(Humanitas University), Elisabetta Sauta(IRCCS Humanitas Research Hospital), Wen‐Chien Chou(National Taiwan University), Saverio D’Amico(Istituti di Ricovero e Cura a Carattere Scientifico), Paola Guglielmelli(Azienda Ospedaliero-Universitaria Careggi), Lorenzo Dall’Olio, Ilaria Carola Casetti(ASST Fatebenefratelli Sacco), Chien‐Chin Lin(National Taiwan University), Anthony M. Hunter(Emory University), Alessia Campagna(Humanitas University), Matteo Zampini(IRCCS Humanitas Research Hospital), David A. Sallman(Moffitt Cancer Center), Angela Consagra(Azienda Ospedaliero-Universitaria Careggi), Erica Travaglino(Policlinico San Matteo Fondazione), Massimo Bernardi(Vita-Salute San Raffaele University), Hwei‐Fang Tien(Far Eastern Memorial Hospital), Anne Sophie Kubasch(Leukemia and Lymphoma Society), Claudia Sala, Tariq Kewan(Yale University), Daniele Dall’Olio(University of Bologna), Vladan Vučinić(University Hospital Leipzig), Somedeb Ball(Vanderbilt University), Manja Meggendorfer(Université Paris-Sud), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Cristina Astrid Tentori(Humanitas University), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Lisa Pleyer(Paracelsus Medical University), Nico Gagelmann(Universität Hamburg), Carmelo Gurnari(University of Rome Tor Vergata), Gabriele Todisco(Humanitas University), Maria Teresa Voso(University of Rome Tor Vergata), Chi‐Yuan Yao(National Taiwan University Hospital), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Marta Ubezio(Humanitas University), Hussein Awada(Cleveland Clinic), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Giulia Maggioni(Humanitas University), Laura Palomo(Fundación Josep Carreras Contra la Leucemia), Gianluca Asti(IRCCS Humanitas Research Hospital), Alessandro Buizza(IRCCS Humanitas Research Hospital), Mattia Delleani(IRCCS Humanitas Research Hospital), Armando Santoro(IRCCS Humanitas Research Hospital), Antonio Russo(Humanitas University), Najla H. Al Ali(Moffitt Cancer Center), Yu‐Hung Wang(University of Manchester), Lorenza Borin(Azienda Ospedaliera San Gerardo), Elena Riva(Humanitas University)
Cited by 2
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821